CU23051A3 - Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas. - Google Patents
Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas.Info
- Publication number
- CU23051A3 CU23051A3 CU20000254A CU20000254A CU23051A3 CU 23051 A3 CU23051 A3 CU 23051A3 CU 20000254 A CU20000254 A CU 20000254A CU 20000254 A CU20000254 A CU 20000254A CU 23051 A3 CU23051 A3 CU 23051A3
- Authority
- CU
- Cuba
- Prior art keywords
- gamma
- prepare
- processes
- compositions containing
- solid compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13311298 | 1998-05-15 | ||
PCT/US1999/010186 WO1999059572A1 (en) | 1998-05-15 | 1999-05-10 | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23051A3 true CU23051A3 (es) | 2005-06-24 |
Family
ID=15097099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20000254A CU23051A3 (es) | 1998-05-15 | 1999-05-10 | Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas. |
Country Status (25)
Country | Link |
---|---|
US (1) | US8623407B2 (es) |
EP (1) | EP1077691B1 (es) |
JP (3) | JP4564607B2 (es) |
KR (1) | KR100669280B1 (es) |
CN (1) | CN100337687C (es) |
AR (1) | AR018609A1 (es) |
AU (1) | AU769038B2 (es) |
BR (1) | BR9910494B1 (es) |
CO (1) | CO5060516A1 (es) |
CU (1) | CU23051A3 (es) |
GT (1) | GT199900068A (es) |
HK (2) | HK1036407A1 (es) |
HU (1) | HU228772B1 (es) |
ID (1) | ID26395A (es) |
IS (1) | IS2983B (es) |
MY (1) | MY127953A (es) |
NO (1) | NO329116B1 (es) |
PA (1) | PA8472701A1 (es) |
PE (1) | PE20000542A1 (es) |
PL (1) | PL205145B1 (es) |
SV (1) | SV1999000063A (es) |
TW (1) | TW592691B (es) |
UY (1) | UY25513A1 (es) |
WO (1) | WO1999059572A1 (es) |
ZA (1) | ZA200006483B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0934061T6 (en) | 1996-07-24 | 2015-01-26 | Warner Lambert Co | Isobutylgaba and its derivatives for the treatment of pain |
YU95302A (sh) * | 2000-06-16 | 2006-05-25 | Teva Pharmaceutical Industries Ltd. | Stabilni gabapentin koji ima ph u kontrolisanom rasponu |
EP1430893A1 (en) * | 2000-06-16 | 2004-06-23 | Teva Pharmaceutical Industries Ltd. | Stable gabapentin containing more than 20 ppm of chloride ion |
ES2193008T3 (es) * | 2000-06-16 | 2004-07-01 | Teva Pharmaceutical Industries Ltd. | Gabapentina estable que contiene mas de 20 ppm de iones de cloro. |
EP1384473A1 (en) * | 2000-06-16 | 2004-01-28 | Teva Pharmaceutical Industries Ltd. | Stable gabapentin containing more than 20 ppm of chlorine ion |
US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
CA2650698C (en) * | 2000-11-17 | 2013-05-28 | Takeda Pharmaceutical Company Limited | Copolyvidone-containing preparation |
CN1720025A (zh) * | 2002-10-08 | 2006-01-11 | 兰贝克赛实验室有限公司 | 加巴喷丁片剂及其制备 |
CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
ITMI20032399A1 (it) | 2003-12-09 | 2005-06-10 | Zambon Spa | Composizione farmaceutica contenente gabapentina. |
CN1921839A (zh) * | 2004-01-19 | 2007-02-28 | 兰贝克赛实验室有限公司 | 加巴喷丁的稳定缓释口服剂型及其制备方法 |
NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
KR20080096779A (ko) * | 2006-01-20 | 2008-11-03 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규 필름 코팅정 |
DE102007019071A1 (de) | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
ES2623328T3 (es) * | 2009-09-18 | 2017-07-11 | Sitec Pharmabio Sl | Procedimiento para la deshidratación de productos en polvo |
HU230031B1 (hu) | 2010-03-01 | 2015-05-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény |
WO2012116402A1 (en) * | 2011-02-28 | 2012-09-07 | Monash University | Binder powders |
US20160338949A1 (en) | 2014-01-28 | 2016-11-24 | Sun Pharmaceutical Industries Limited | Stabilized gastroretentive tablets of pregabalin |
US10561602B2 (en) | 2015-05-26 | 2020-02-18 | Isa Odidi | Controlled extended release pregabalin |
JP7276760B2 (ja) * | 2016-12-08 | 2023-05-18 | 日本ケミファ株式会社 | 4-アミノ-3-ブタン酸類縁体含有固形製剤 |
JP6919119B2 (ja) * | 2017-01-23 | 2021-08-18 | 日新製薬株式会社 | 3位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 |
JP2019052147A (ja) * | 2017-09-13 | 2019-04-04 | 大原薬品工業株式会社 | 化学的な安定性が改善された、プレガバリン含有口腔内崩壊錠 |
JP7138666B2 (ja) * | 2018-01-24 | 2022-09-16 | 大原薬品工業株式会社 | γ-アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
AR115354A1 (es) * | 2018-04-24 | 2020-12-23 | Shionogi & Co | Forma de dosis sólida con excelente estabilidad |
MX2020011130A (es) * | 2018-04-24 | 2022-09-09 | Shionogi & Co | Forma de dosificacion solida que tiene excelente estabilidad. |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4115553A (en) * | 1973-12-10 | 1978-09-19 | Armour Pharmaceutical Company | Antacid tablets |
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4126684A (en) * | 1976-02-11 | 1978-11-21 | Ciba-Geigy Corporation | 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse |
GB8504093D0 (en) * | 1985-02-18 | 1985-03-20 | Ici Plc | Alkene alkyne/cycloalkylene derivatives |
US4486412A (en) * | 1983-03-15 | 1984-12-04 | Pharmacaps, Inc. | Encapsulated antacid dispersions |
CA1249968A (en) * | 1984-04-05 | 1989-02-14 | Kazuo Kigasawa | Ointment base |
JPS63253022A (ja) * | 1987-04-08 | 1988-10-20 | Nitto Electric Ind Co Ltd | バクロフエン外用製剤 |
PH26730A (en) | 1988-12-30 | 1992-09-28 | Ciba Geigy Ag | Coated adhesive tablets |
DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
US5084479A (en) | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
EP0458751A1 (en) * | 1990-05-25 | 1991-11-27 | Warner-Lambert Company | Delivery system for cyclic amino acids with improved taste, texture and compressibility |
US5025035A (en) | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
DE59307753D1 (de) * | 1992-03-11 | 1998-01-15 | Asta Medica Ag | Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen |
US5510381A (en) | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
-
1999
- 1999-05-10 HU HU0101791A patent/HU228772B1/hu not_active IP Right Cessation
- 1999-05-10 EP EP99924164A patent/EP1077691B1/en not_active Expired - Lifetime
- 1999-05-10 KR KR1020007012757A patent/KR100669280B1/ko not_active IP Right Cessation
- 1999-05-10 ID IDW20002233A patent/ID26395A/id unknown
- 1999-05-10 CU CU20000254A patent/CU23051A3/es unknown
- 1999-05-10 PL PL344219A patent/PL205145B1/pl unknown
- 1999-05-10 WO PCT/US1999/010186 patent/WO1999059572A1/en active IP Right Grant
- 1999-05-10 BR BRPI9910494-6A patent/BR9910494B1/pt not_active IP Right Cessation
- 1999-05-10 CN CNB200410077021XA patent/CN100337687C/zh not_active Expired - Fee Related
- 1999-05-10 AU AU40733/99A patent/AU769038B2/en not_active Ceased
- 1999-05-12 TW TW088107705A patent/TW592691B/zh not_active IP Right Cessation
- 1999-05-13 MY MYPI99001898A patent/MY127953A/en unknown
- 1999-05-13 PA PA19998472701A patent/PA8472701A1/es unknown
- 1999-05-14 JP JP13376999A patent/JP4564607B2/ja not_active Expired - Lifetime
- 1999-05-14 GT GT199900068A patent/GT199900068A/es unknown
- 1999-05-14 PE PE1999000406A patent/PE20000542A1/es not_active Application Discontinuation
- 1999-05-14 SV SV1999000063A patent/SV1999000063A/es active IP Right Grant
- 1999-05-14 AR ARP990102312A patent/AR018609A1/es active IP Right Grant
- 1999-05-14 UY UY25513A patent/UY25513A1/es not_active IP Right Cessation
- 1999-05-14 CO CO99030159A patent/CO5060516A1/es unknown
-
2000
- 2000-09-29 IS IS5647A patent/IS2983B/is unknown
- 2000-11-09 ZA ZA200006483A patent/ZA200006483B/en unknown
- 2000-11-14 NO NO20005765A patent/NO329116B1/no not_active IP Right Cessation
-
2001
- 2001-10-18 HK HK01107302A patent/HK1036407A1/xx not_active IP Right Cessation
-
2002
- 2002-06-28 JP JP2002189768A patent/JP3527729B2/ja not_active Expired - Lifetime
-
2003
- 2003-10-31 JP JP2003371461A patent/JP3944150B2/ja not_active Expired - Lifetime
-
2005
- 2005-06-29 HK HK05105487A patent/HK1072729A1/xx not_active IP Right Cessation
-
2008
- 2008-11-19 US US12/273,692 patent/US8623407B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23051A3 (es) | Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas. | |
PT1095932E (pt) | Derivados de acido fenoxiacetico e composicoes medicinais que os contem | |
EE200000725A (et) | Uued 3-arüülpropaanhappe derivaadid ja nende analoogid | |
PT1070069E (pt) | Derivados biciclicos do acido hidroxamico | |
PT1070058E (pt) | Hidroxiamidas de acido (4-aril-sulfonilamino)-tetra-hidropirano-4-carboxilico | |
DE69813922D1 (de) | Hydroxycarbonsäure oder Retinoid enthaltende Zusammensetzungen | |
DE69927969D1 (de) | Kontrollierte freisetzung von liponsäure | |
IT1289155B1 (it) | Composizioni granulari di acido e-ftalimmido perossiesanoico | |
PT1077957E (pt) | Derivados do acido oxi-iminoalcanoico | |
HUP0101894A2 (hu) | IgE csökkentő hatású benzimidazolszármazékokat tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
BR9708793A (pt) | Composições ácidas redutoras de cisalhamento espessas | |
PT1066027E (pt) | Composicao farmaceutica de topiramato | |
HUP0100819A3 (en) | Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them | |
PT1100327E (pt) | Microcapsulas de libertacao despoletada por acido | |
BR9704554A (pt) | Utilização de lipídios complexos como adições de estabilização para composições farmacêuticas de misturas de enzimas de digestão | |
BR9710884A (pt) | Produ-Æo e uso de composi-{es compreendendo altas concentra-{es de atividade de vitamina b12 | |
PT83909B (pt) | Processo para a preparacao de 5-amino e 5-hidroxi-6,8-difluoroquinolonas e de composicoes farmaceuticas antibacterianas que as contem | |
NO983979D0 (no) | Fremgangsmåte ved nedsettelse av det totale syretall i råolje | |
AR016694A1 (es) | Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion. | |
EE9500059A (et) | Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena | |
MX9205916A (es) | Derivados de acido ciclohexanoacetico, proceso para su preparacion y composicion farmaceutica que los comprende | |
AR002253A1 (es) | Compuesto derivado de fenil-alcanol biocida composición que lo contiene y procesos para producirlo | |
PT1049721E (pt) | Polissacaridos de sintese processo para a sua preparacao e composicoes farmaceuticas que os contem | |
PT897667E (pt) | Composicao para melhorar o pao |